GET THE APP
Modeling the level of Bcr-Abl oncoprotein in K562 cells by i | 89109
ejco

European Journal of Clinical Oncology

ISSN - 2732-2654

Abstract

Modeling the level of Bcr-Abl oncoprotein in K562 cells by inhibiting USP1 deubiquitinase

Svitlana Antonenko

Statement of the Problem: The development of chronic myeloid leukemia (CML) is caused by oncoprotein Bcr-Abl.

iomcworld scan

Journal Highlights

Journal Flyer

Flyer

+44 7362049920

Top